Stock Analysis on Net

Eli Lilly & Co. (NYSE:LLY)

Income Statement
Quarterly Data

Eli Lilly & Co., consolidated income statement (quarterly data)

US$ in thousands

Microsoft Excel
3 months ended: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue 9,353,400 9,498,600 8,312,100 6,960,000 7,301,800 6,941,600 6,488,000 7,810,000 7,999,900 6,772,800 6,740,100 6,805,600 7,440,000 5,740,600 5,499,400 5,859,800 6,114,000 5,476,600 5,636,700 5,092,200
Cost of sales (1,788,000) (1,860,100) (1,807,400) (1,626,700) (1,548,100) (1,579,100) (1,430,500) (2,072,100) (2,050,200) (1,430,800) (1,953,200) (1,878,600) (1,719,800) (1,326,400) (1,222,000) (1,215,100) (1,282,600) (1,175,000) (1,124,900) (1,138,700)
Gross margin 7,565,400 7,638,500 6,504,700 5,333,300 5,753,700 5,362,500 5,057,500 5,737,900 5,949,700 5,342,000 4,786,900 4,927,000 5,720,200 4,414,200 4,277,400 4,644,700 4,831,400 4,301,600 4,511,800 3,953,500
Research and development (2,562,700) (2,409,100) (2,356,500) (1,985,100) (1,995,900) (1,802,900) (1,781,900) (1,610,100) (1,898,300) (1,705,300) (1,655,000) (1,672,100) (1,838,000) (1,465,400) (1,390,200) (1,392,100) (1,581,400) (1,380,900) (1,402,200) (1,230,500)
Marketing, selling, and administrative (1,924,600) (1,803,900) (1,925,400) (1,749,200) (1,643,200) (1,614,200) (1,625,100) (1,557,900) (1,592,000) (1,577,900) (1,685,700) (1,576,000) (1,553,900) (1,569,100) (1,448,600) (1,549,600) (1,698,100) (1,412,300) (1,586,300) (1,517,100)
Acquired in-process research and development (622,600) (2,975,100) (97,100) (105,000) (240,100) (62,400) (440,400) (165,600) (437,700) (177,600) (42,800) (312,000) (366,300) (241,800) (52,300) (77,700) (25,000) (136,900)
Asset impairment, restructuring, and other special charges (67,700) (38,100) (206,500) (104,500) (211,600) 30,100 (101,400) (59,900) (151,700) (423,900)
Operating income 2,387,800 450,400 2,125,700 1,494,000 1,836,400 1,676,500 1,210,100 2,404,300 1,917,200 1,881,200 1,403,400 1,155,300 1,992,100 1,278,300 1,196,800 1,590,800 1,400,200 1,430,700 1,498,300 645,100
Other, net, income (expense) 121,000 (23,200) (36,800) 35,700 260,000 (111,000) (119,200) (350,700) (77,300) (635,900) 190,500 321,100 477,000 158,900 446,900 89,100 262,900 (24,900) (32,400) 86,000
Income before income taxes 2,508,800 427,200 2,088,900 1,529,700 2,096,400 1,565,500 1,090,900 2,053,600 1,839,900 1,245,300 1,593,900 1,476,400 2,469,100 1,437,200 1,643,700 1,679,900 1,663,100 1,405,800 1,465,900 731,100
Income taxes (319,100) (484,600) (325,700) (184,800) (158,700) (113,800) (138,400) (150,700) (113,800) (135,200) (203,700) (121,100) (352,300) (228,800) (231,700) (223,400) (167,400) (151,900) (138,700) (170,000)
Net income (loss) from continuing operations 2,189,700 (57,400) 1,763,200 1,344,900 1,937,700 1,451,700 952,500 1,902,900 1,726,100 1,110,100 1,390,200 1,355,300 2,116,800 1,208,400 1,412,000 1,456,500 1,495,700 1,253,900 1,327,200 561,100
Net income from discontinued operations 3,680,500
Net income (loss) 2,189,700 (57,400) 1,763,200 1,344,900 1,937,700 1,451,700 952,500 1,902,900 1,726,100 1,110,100 1,390,200 1,355,300 2,116,800 1,208,400 1,412,000 1,456,500 1,495,700 1,253,900 1,327,200 4,241,600

Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Income statement item Description The company
Revenue Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Eli Lilly & Co. revenue increased from Q2 2023 to Q3 2023 but then slightly decreased from Q3 2023 to Q4 2023.
Operating income The net result for the period of deducting operating expenses from operating revenues. Eli Lilly & Co. operating income decreased from Q2 2023 to Q3 2023 but then increased from Q3 2023 to Q4 2023 exceeding Q2 2023 level.
Income before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Eli Lilly & Co. income before income taxes decreased from Q2 2023 to Q3 2023 but then increased from Q3 2023 to Q4 2023 exceeding Q2 2023 level.
Net income (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Eli Lilly & Co. net income (loss) decreased from Q2 2023 to Q3 2023 but then increased from Q3 2023 to Q4 2023 exceeding Q2 2023 level.